{
    "2018-03-30": [
        [
            {
                "time": "2018-01-03",
                "original_text": "How Did Novartis’s Established Medicines Segment Perform in 2017?",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Established Medicines",
                        "Performance",
                        "2017"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "The Week Ahead In Biotech: PDUFA Dates, Clinical Trials And Conferences",
                "features": {
                    "keywords": [
                        "Biotech",
                        "PDUFA",
                        "Clinical Trials",
                        "Conferences"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "How Regeneron Pharmaceuticals’ Eylea Performed in 4Q17 and 2017",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "Eylea",
                        "4Q17",
                        "2017"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "How Is Novartis’s Xolair Positioned after 4Q17?",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Xolair",
                        "4Q17"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "A Look at Novartis’s Immunology and Dermatology Segment’s Performance",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Immunology",
                        "Dermatology",
                        "Performance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}